Guide

Outsourcing sales operations or building in-house

A growing medical or pharma company that turns to outbound faces this choice early. The answer depends on time, stage and whether the company wants to own the capability at the end.

The short answer

Outsourcing suits a company that needs speed and expertise without fixed cost. Building in-house suits a company with time, a proven motion and complex, high-value relationships to protect. Most land on a hybrid, outsourcing the build and the top of the funnel while keeping closing and key accounts inside.

When outsourcing wins

A specialist partner stands up capacity in weeks rather than the months it takes to hire, onboard and ramp a team. Salaries, benefits and tooling become a variable cost that scales up or down. The company buys expertise in deliverability, data or a niche such as diagnostics, and the partner carries the trial and error of finding message and market fit. For a launch, a short surge or a new territory, that speed is usually decisive.

When building in-house wins

An in-house team wins on control and depth. Its people know the product, sit close to marketing and medical affairs, and build long relationships with key opinion leaders, department chairs and procurement committees. For flagship products sold on a scientific relationship, that depth is hard to replicate.

The cost is time and carry. Companies also underestimate the layer under the reps, the data, deliverability, CRM discipline and reporting. Hiring a salesperson is different from building a sales operation.

The trade-off, side by side

  • Outsourcing reaches capacity in weeks, and an in-house team takes months.
  • Control is set by the contract when outsourced, and it is full in-house.
  • In a pure agency model the partner keeps the capability at the end, and in-house the company does.
  • The manufacturer generally keeps responsibility for compliant commercial activity in both cases.

What drives the cost on each side?

In-house cost is mostly fixed, in salaries, recruiting, months of ramp, the tooling under the team and a manager's time, and a departure resets part of it. Outsourced cost is mostly variable, and the tooling often sits in the provider's name, so an exit can mean rebuilding the infrastructure.

The option most companies miss

The question assumes two answers. A build, run and own partner outsources the build and still leaves an in-house engine. It designs the outbound unit, proves it in market, then hands over the domains, data, messaging, dashboards, playbook and a trained operator.

A simple decision framework

  • Capacity needed in weeks points to outsourcing, or to a build partner that starts from warmed assets.
  • A launch or a defined surge suits outsourcing or a contract sales organization.
  • Value held in a deep scientific relationship stays in-house, with the top of the funnel outsourced to feed it.
  • Ownership of the capability afterward rules out a pure agency.
  • A weak data, deliverability or CRM layer makes the engine matter more than extra reps.

Enquirer offers the third option as a fixed four-month build within its sales and go-to-market practice.

Enquirer works with medical, pharma and other B2B companies on sales and go-to-market.

Talk to us